- Home
- SST vs CELU Comparison
SST vs CELU Comparison
Compare SST & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SST | CELU |
|---|---|---|
| Founded | 2013 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.8M | 17.3M |
| IPO Year | 2020 | 2019 |
Fundamental Metrics
Financial Performance| Metric | SST | CELU |
|---|---|---|
| Price | $1.70 | $0.81 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 55.6K | ★ 153.4K |
| Earning Date | 11-13-2026 | 10-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.04 |
| Revenue | ★ $266,129,000.00 | $26,550,000.00 |
| Revenue This Year | N/A | $165.42 |
| Revenue Next Year | $21.02 | $305.36 |
| P/E Ratio | ★ N/A | $21.72 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.35 | $0.56 |
| 52 Week High | $6.05 | $2.55 |
Technical Indicators
Market Signals| Indicator | SST | CELU |
|---|---|---|
| Relative Strength Index (RSI) | 30.68 | 35.81 |
| Support Level | $1.68 | $0.63 |
| Resistance Level | $2.09 | $0.86 |
| Average True Range (ATR) | 0.19 | 0.16 |
| MACD | -0.03 | -0.05 |
| Stochastic Oscillator | 8.41 | 15.73 |
Price Performance
Historical ComparisonAbout SST System1 Inc.
System1 Inc develops technology and data science to operate a responsive acquisition marketing platform. It operate several flagship brands across multiple consumer verticals, including shopping, travel and search, and a customer acquisition and marketing platform powered by Artificial Intelligence and machine learning. The company's segment includes Marketing and Products. It generates maximum revenue from the Marketing segment. Geographically, it operates in United States and Other countries.
About CELU Celularity Inc.
Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.